40 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
guides, communication plans for healthcare professionals, and elements to assure safe use (“ETASU”). ETASU can include, but is not limited to, specific … on third-party payors to reimburse all or part of the associated healthcare costs. Patients are unlikely to use any product candidates we may develop unless
8-K
EX-99.1
CRBU
Caribou Biosciences Inc
8 Jan 24
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024
8:00am
AML expected H1 2024 --
-- Caribou to present at 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, at 11:15 am PST --
BERKELEY … .
Caribou to present at the 42nd Annual J.P. Morgan Healthcare Conference
Dr. Haurwitz is scheduled to present a corporate update at the 42nd Annual J.P
ARS
5m1fyms hzin
28 Apr 23
Annual report to shareholders
12:00am
8-K
EX-99.1
ljnq972urk
8 Nov 22
Caribou Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
4:05pm
DEF 14A
ydfu3 9mx9mxklke
11 Aug 22
Definitive proxy
4:04pm
8-K
EX-99.1
hgfai6 5zcztfai4
9 Aug 22
Caribou Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
12:00am
S-3
pw9stc75v61
9 Aug 22
Shelf registration
12:00am
10-K
4ex7vvsjpha63gba
21 Mar 22
Annual report
4:19pm
8-K
EX-99.1
pm0gnmqn 29maoc
9 Nov 21
Caribou Biosciences Provides Business Update and Reports Third Quarter 2021 Financial Results
4:12pm